ATE236185T1 - Makrozyklische derivate von erythromycin a und b mit 13 ringatomen - Google Patents
Makrozyklische derivate von erythromycin a und b mit 13 ringatomenInfo
- Publication number
- ATE236185T1 ATE236185T1 AT97922483T AT97922483T ATE236185T1 AT E236185 T1 ATE236185 T1 AT E236185T1 AT 97922483 T AT97922483 T AT 97922483T AT 97922483 T AT97922483 T AT 97922483T AT E236185 T1 ATE236185 T1 AT E236185T1
- Authority
- AT
- Austria
- Prior art keywords
- erythromycin
- ring atoms
- macrocyclic derivatives
- hypermotilinemia
- pharmaceutical compositions
- Prior art date
Links
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical class O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 title abstract 2
- IDRYSCOQVVUBIJ-UHFFFAOYSA-N Erythromycin-B Natural products CC1C(OC2C(C(CC(C)O2)N(C)C)O)C(C)(O)CC(C)C(=O)C(C)C(O)C(C)C(CC)OC(=O)C(C)C1OC1CC(C)(OC)C(O)C(C)O1 IDRYSCOQVVUBIJ-UHFFFAOYSA-N 0.000 title 1
- IDRYSCOQVVUBIJ-PPGFLMPOSA-N erythromycin B Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@H]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)C)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 IDRYSCOQVVUBIJ-PPGFLMPOSA-N 0.000 title 1
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/668,050 US5712253A (en) | 1996-06-18 | 1996-06-18 | Macrocyclic 13-membered ring derivatives of erythromycins A and B |
| PCT/US1997/007015 WO1997048713A1 (en) | 1996-06-18 | 1997-04-25 | Macrocyclic 13-membered ring derivatives of erythromycins a and b |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE236185T1 true ATE236185T1 (de) | 2003-04-15 |
Family
ID=24680797
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97922483T ATE236185T1 (de) | 1996-06-18 | 1997-04-25 | Makrozyklische derivate von erythromycin a und b mit 13 ringatomen |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5712253A (de) |
| EP (1) | EP1021456B1 (de) |
| JP (1) | JP2000512653A (de) |
| AT (1) | ATE236185T1 (de) |
| CA (1) | CA2257361A1 (de) |
| DE (1) | DE69720551T2 (de) |
| DK (1) | DK1021456T3 (de) |
| ES (1) | ES2196331T3 (de) |
| PT (1) | PT1021456E (de) |
| WO (1) | WO1997048713A1 (de) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4968997A (en) * | 1996-11-26 | 1998-06-22 | Chugai Seiyaku Kabushiki Kaisha | 13-membered ring macrolide compounds, medicine containing the same, and process for producing the same |
| TW460478B (en) | 1997-08-15 | 2001-10-21 | Chugai Pharmaceutical Co Ltd | Phenethylamine derivatives |
| US5780605A (en) * | 1997-09-08 | 1998-07-14 | Abbott Laboratories | 6,9-bridged erythromycin derivatives |
| US6165985A (en) * | 1998-02-13 | 2000-12-26 | Solvay Pharmaceuticals Gmbh | 11-acetyl-12,13-dioxabicyclo[8.2.1]-tridecenone derivatives, processes for their preparation and pharmaceutical compositions comprising them |
| DE19805822B4 (de) * | 1998-02-13 | 2009-02-05 | Solvay Pharmaceuticals Gmbh | 11-Acetyl-12,13-dioxabicyclo[8.2.1]tridecenon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| CA2330251A1 (en) * | 1998-06-12 | 1999-12-16 | Merck & Co., Inc. | Cloning and identification of the motilin receptor |
| TW509699B (en) | 1998-09-24 | 2002-11-11 | Chugau Pharmaceutical Co Ltd | Ethylamine derivatives |
| EP1149843A4 (de) | 1999-01-28 | 2012-06-06 | Chugai Pharmaceutical Co Ltd | Substituierte phenethylamin-derivate |
| US7179886B1 (en) | 1999-06-08 | 2007-02-20 | Merck & Co., Inc. | Cloning and identification of the motilin receptor |
| AU2001238476A1 (en) | 2000-02-18 | 2001-08-27 | Kosan Biosciences, Inc. | Motocide compounds |
| AU2002245051A1 (en) * | 2000-11-29 | 2002-07-30 | Lifespan Biosciences, Inc. | Diagnostic and therapeutic compositions and methods related to grp 38 |
| US20030186336A1 (en) * | 2001-11-29 | 2003-10-02 | Burmer Glenna C. | Diagnostic and therapeutic compositions and methods related to GPCR 38, a G protein-coupled receptor (GPCR) |
| CN100363359C (zh) * | 2002-08-29 | 2008-01-23 | 菲塞股份有限公司 | 运动内酯化合物 |
| TW200420573A (en) | 2002-09-26 | 2004-10-16 | Rib X Pharmaceuticals Inc | Bifunctional heterocyclic compounds and methods of making and using same |
| WO2004111077A1 (en) * | 2003-06-18 | 2004-12-23 | Tranzyme Pharma Inc. | Macrocyclic antagonists of the motilin receptor |
| US7452862B2 (en) | 2003-07-31 | 2008-11-18 | Tranzyme Pharma, Inc. | Conformationally-controlled biologically active macrocyclic small molecules as motilin antagonists or ghrelin agonists |
| EP1648923B1 (de) * | 2003-07-31 | 2008-12-31 | Tranzyme Pharma Inc. | Räumlich definierte makrocyclen, die peptidbindungssurrogate enthalten |
| US20050113319A1 (en) * | 2003-08-26 | 2005-05-26 | Christopher Carreras | 11-Deoxy-6,9-ether erythromycin compounds |
| US7407941B2 (en) * | 2003-08-26 | 2008-08-05 | Pfizer, Inc. | N-desmethyl-N-substituted-11-deoxyerythromycin compounds |
| US7211568B2 (en) * | 2003-12-18 | 2007-05-01 | Kosan Biosciences Incorporated | 9-Desoxoerythromycin compounds as prokinetic agents |
| US8202843B2 (en) | 2004-02-27 | 2012-06-19 | Rib-X Pharmaceuticals, Inc. | Macrocyclic compounds and methods of making and using the same |
| US20080249034A1 (en) * | 2005-03-21 | 2008-10-09 | Zambon S.P.A. | Use of Macrolides for Treating Intestinal Inflammation |
| WO2006102350A1 (en) * | 2005-03-23 | 2006-09-28 | Washington University In St. Louis | The use of archaea to modulate the nutrient harvesting functions of the gastrointestinal microbiota |
| US7582611B2 (en) * | 2005-05-24 | 2009-09-01 | Pfizer Inc. | Motilide compounds |
| US20070135362A1 (en) * | 2005-12-08 | 2007-06-14 | Yaoquan Liu | Method for demethylating the 3'-dimethylamino group of erythromycin compounds |
| US8088733B2 (en) | 2006-07-06 | 2012-01-03 | Tranzyme Pharma Inc. | Methods of using macrocyclic agonists of the ghrelin receptor for treatment of gastrointestinal motility disorders |
| EP2431380A3 (de) | 2006-09-11 | 2013-07-03 | Tranzyme Pharma, Inc. | Makrozyklischer Antagonist des Motilinrezeptors zur Behandlung von Magen-Darm-Motilitätsstörungen |
| RU2422453C2 (ru) | 2006-12-05 | 2011-06-27 | Пфайзер Инк. | Полиморфы мотилида |
| US20080287371A1 (en) * | 2007-05-17 | 2008-11-20 | Tranzyme Pharma Inc. | Macrocyclic antagonists of the motilin receptor for modulation of the migrating motor complex |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3878192A (en) * | 1972-06-05 | 1975-04-15 | Blasina Lab Chim Farm | Sweet and palatable water soluble derivatives of erythromycin |
| JPS6187625A (ja) * | 1984-10-05 | 1986-05-06 | Satoshi Omura | 消化管収縮運動促進剤 |
| US5008249A (en) * | 1985-08-31 | 1991-04-16 | Kitasato Kenkyusho | Therapeutic method of stimulating digestive tract contractile motion in mammals |
| DE3689758T2 (de) * | 1985-08-31 | 1994-08-18 | Kitasato Inst | Erythromycinderivat und Verfahren zu dessen Herstellung. |
| US4640910A (en) * | 1985-11-12 | 1987-02-03 | Abbott Laboratories | Erythromycin A silylated compounds and method of use |
| US4681872A (en) * | 1985-11-12 | 1987-07-21 | Abbott Laboratories | Erythromycin A 11,12-carbonate and method of use |
| JPS63107994A (ja) * | 1986-05-02 | 1988-05-12 | Taisho Pharmaceut Co Ltd | エリスロマイシン誘導体 |
| MY103197A (en) * | 1987-02-20 | 1993-05-29 | Kitasato Inst | A growth promoting composition and production thereof |
| US4920102A (en) * | 1988-04-18 | 1990-04-24 | Eli Lilly And Company | Method for treating gastrointestinal disorders |
-
1996
- 1996-06-18 US US08/668,050 patent/US5712253A/en not_active Expired - Lifetime
-
1997
- 1997-04-25 EP EP97922483A patent/EP1021456B1/de not_active Expired - Lifetime
- 1997-04-25 WO PCT/US1997/007015 patent/WO1997048713A1/en not_active Ceased
- 1997-04-25 AT AT97922483T patent/ATE236185T1/de not_active IP Right Cessation
- 1997-04-25 ES ES97922483T patent/ES2196331T3/es not_active Expired - Lifetime
- 1997-04-25 CA CA002257361A patent/CA2257361A1/en not_active Abandoned
- 1997-04-25 PT PT97922483T patent/PT1021456E/pt unknown
- 1997-04-25 DE DE69720551T patent/DE69720551T2/de not_active Expired - Fee Related
- 1997-04-25 DK DK97922483T patent/DK1021456T3/da active
- 1997-04-25 JP JP10502937A patent/JP2000512653A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| US5712253A (en) | 1998-01-27 |
| DE69720551D1 (de) | 2003-05-08 |
| CA2257361A1 (en) | 1997-12-24 |
| ES2196331T3 (es) | 2003-12-16 |
| JP2000512653A (ja) | 2000-09-26 |
| WO1997048713A1 (en) | 1997-12-24 |
| DE69720551T2 (de) | 2004-02-26 |
| DK1021456T3 (da) | 2003-08-18 |
| PT1021456E (pt) | 2003-08-29 |
| EP1021456B1 (de) | 2003-04-02 |
| EP1021456A1 (de) | 2000-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE236185T1 (de) | Makrozyklische derivate von erythromycin a und b mit 13 ringatomen | |
| AP9801378A0 (en) | 9-amino-3- keto erythromycin derivatives. | |
| ZA9711607B (en) | Novel cyclosporin derivatives, their preparation and the pharmaceutical compositions which contain them. | |
| CA2258548A1 (en) | Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases | |
| IL124537A0 (en) | Naphthyl-substituted benzimidazole derivatives and pharmaceutical compositions containing the same | |
| AP9801253A0 (en) | 9-Oxime erythromycin derivatives. | |
| ZA9711606B (en) | Cyclosporin derivatives, their preparation and the pharmaceutical compositions which contain them. | |
| TR200103395T2 (tr) | 13-metil eritromisin türevleri. | |
| AU697679B2 (en) | Treatment of tinnitis using neuroprotective agents | |
| GB9322643D0 (en) | Lactam derivatives | |
| DK0876388T3 (da) | Tricykliske erythromycinderivater | |
| DE69317877D1 (en) | 4''-deoxyerythromycinderivate | |
| ATE211729T1 (de) | Therapeutisch wirksame verbindungen | |
| CA2146763A1 (en) | Quinolone and acridinone derivatives for the treatment of urinary incontinence | |
| CA2286511A1 (en) | Novel macrolide derivatives | |
| ZA955793B (en) | Benzothiadiazine compound process for its preparation and the pharmaceutical compositions which contain it | |
| AP9801377A0 (en) | Tricyclic erythromycin derivatives. | |
| DE69330601D1 (de) | Serotoninergische ergolin derivate | |
| AP9801235A0 (en) | Erythromycin derivatives. | |
| AP9901559A0 (en) | Tricyclic 3-keto derivatives of 6-0-methylerythromycin. | |
| ATE231878T1 (de) | 3-deoxy-3-descladinosederivate von erythromycin a und b |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1021456 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |